Cargando…

Psychosocial controversies in breast cancer

Detalles Bibliográficos
Autor principal:	Fallowfield, Lesley
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Section Introduction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230510/ http://dx.doi.org/10.1186/bcr1800

Ejemplares similares

Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'
por: Fallowfield, Lesley, et al.
Publicado: (2008)

Controversies in Breast Cancer 2010
por: Miller, William R
Publicado: (2010)

Controversies in Breast Cancer 2009
por: Miller, William R
Publicado: (2009)

The globalisation of breast cancer
por: Boyle, Peter, et al.
Publicado: (2010)

Introduction to sessions on 'Predicting personal risk for breast cancer'
por: Dowsett, Mitch
Publicado: (2008)

Qualitative research and pain: Current controversies and future directions
por: Tutelman, Perri R., et al.
Publicado: (2020)

Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6
por: Wishart, Gordon C, et al.
Publicado: (2009)

Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
por: Del Prato, Stefano, et al.
Publicado: (2013)

Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
por: Raz, Itamar, et al.
Publicado: (2016)

Psychosocial program standards for NICU parents
por: Hynan, M T, et al.
Publicado: (2015)

Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Dilemmas in clinical practice
por: Raz, Itamar
Publicado: (2009)

Controversial issues in visual cortex mapping: Extrastriate cortex between areas V2 and MT in human and nonhuman primates
por: Angelucci, Alessandra, et al.
Publicado: (2015)

Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Outcome studies versus clinical experience in the treatment of diabetes
por: Raz, Itamar, et al.
Publicado: (2011)

Introduction to sessions on Personalising treatment
por: Dowsett, Mitch, et al.
Publicado: (2007)

Introduction: challenging established dogma
por: Santen, Richard J
Publicado: (2007)

Introduction to clinical research sessions
por: Ingle, James N
Publicado: (2007)

Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'
por: Ingle, James N
Publicado: (2008)

Introduction to sessions on 'Optimizing the implementation of future treatments – time to abandon traditional methods'
por: Verrill, Mark
Publicado: (2008)

Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'
por: Dixon, J Michael, et al.
Publicado: (2008)

Predictive and prognostic factors
por: Dowsett, Mitch
Publicado: (2010)

Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry
por: Weigelt, Britta, et al.
Publicado: (2010)

Introduction to session on undue and disproportionate influences
por: Ingle, James N, et al.
Publicado: (2010)

Session 6 introduction
por: Robertson, John FR, et al.
Publicado: (2010)

Introduction: are current drug development programmes realising the full potential of new agents?
por: Johnston, Stephen RD, et al.
Publicado: (2010)

Risk factors. Introduction to Session 1
por: Howell, Anthony, et al.
Publicado: (2009)

Debate: tailored targeted therapy for all - a realistic and worthwhile objective? Introduction to Session 2
por: Smith, Ian E
Publicado: (2009)

The potential of new technologies/approaches. Introduction to Sessions 3 and 4
por: Dowsett, Mitch
Publicado: (2009)

Who would have thought it! Influence on outcome of radiotherapy, Ki67 and stroma. Introduction to Session 5
por: Rodger, Alan
Publicado: (2009)

Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8
por: Johnston, Stephen RD
Publicado: (2009)

Defining Drugs in the Electrophysiologist’s World
por: Reiffel, James A.
Publicado: (2017)

The optimal approach to early breast cancer
por: Wyld, Lynda
Publicado: (2013)

The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner
por: Hanna, Kirollos, et al.
Publicado: (2021)

Occupational cancer burden in Great Britain
por: Rushton, Lesley, et al.
Publicado: (2012)

Compulsory treatment in the community: concept and controversy
por: Skuse, David
Publicado: (2009)

Special Issue: DNA Repair and Somatic Repeat Expansion in Huntington’s Disease
por: Jones, Lesley, et al.
Publicado: (2021)

Breast radiology: New horizons in times of pandemics()
por: Pina, L.
Publicado: (2022)

Psychosocial aspects of risk appraisal
por: Fallowfield, Lesley
Publicado: (2008)

Treatment of Colorectal Cancer and Other GI Cancers in the COVID-19 Pandemic
por: Chu, Edward
Publicado: (2020)

Cancer-associated thrombosis
por: Kakkar, A K
Publicado: (2010)

Optimal approach for renal cancer
por: Sternberg, Cora N.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jptq1ah61o0arsnfrf62f0c89k